American CryoStem (OTCQB:CRYO) Announces Partnership With Orlando Florida Medical Rejuvenation Center (Eterna M.D.) to Offer AT
January 30 2013 - 9:52AM
American CryoStem Corporation (OTCQB:CRYO), a leading biotech
company in the field of Regenerative Medicine, is proud to announce
that Eterna M.D. of Orlando, FL will be offering American
CryoStem's new ATGRAFT™ fat storage service to their patients for
future natural cosmetic enhancements.
By using the ATGRAFT™ fat storage service, Eterna M.D. patients
can access selected sizes of their stored fat to undergo layered
fat transfer procedures over time.
With this new service, a patient can undergo a standard
liposuction and store their excess body fat as a natural
biocompatible filler for a fuller, more natural look and feel for
immediate or future use in cosmetic enhancement procedures. Demand
for liposuction surgery has been on the rise and thanks to new
technologies patients can make good use of their unwanted body fat
resulting from a liposuction and save it for future procedures.
Fat transfers offer the most natural look and feel for aesthetic
augmentation and corrective cosmetic procedures. An alternative to
synthetic materials, patients can use fat from an undesired
location to enhance a multitude of areas throughout their body.
Storing a patient's fat tissue for cosmetic enhancements provides
them with many benefits not available from a one-time fat transfer
procedure. Patients can now have one liposuction and simply visit
Eterna M.D. for multiple transfer procedures by using their stored
tissue for more a pleasing, natural result.
"The wave of the future for cosmetic and regenerative medicine
relies on fat transfer and storage. Having the ability to store the
fat and retrieve it to be used either as "intelligent fillers" or
for future Regenerative Medicine procedures since they are rich in
growth factors and stem cells," stated Dr. Mercado, owner of Eterna
M.D. "I firmly believe this the way of the future, to store your
fat following liposuction procedures for future cosmetic procedures
or to retrieve your stem cells from your own stored fat for
clinical applications such as osteoarthritis and sports injury is a
breakthrough in medicine."
American CryoStem's ATGRAFT™ tissue storage customers also have
additional opportunities to further process portions of their
clinically prepared adipose tissue samples for future uses in
Regenerative Medicine therapies or to create personalized skin care
products made from their own adult stem cells.
Physicians that would like to offer ATGRAFT(TM) tissue storage
services to their patients should call 732-747-1007 or email
info@americancryostem.com for an informational kit.
About American CryoStem: American CryoStem
Corporation (OTCQB:CRYO) is a leading biotech company focused on
marketing its clinical processing services and patented products
for adipose (fat) tissue and adipose derived adult stem cells. Our
clinical tissue processing, patented cell culture media products
and tissue storage platform supports cosmetic and regenerative
medicine applications being developed globally. The Company
provides high quality, clinically processed viable cells, while at
the same time developing cutting edge applications, therapies,
patented laboratory products and services for consumer and
commercial applications.
Cautionary Statements Concerning Forward-Looking Statements
This Press Release contains "forward-looking" statements as
defined in the Private Securities Litigation Reform Act of 1995.
These statements are based on management's current expectations or
predictions of future conditions, events or results based on
various assumptions and management's estimates of trends and
economic factors in the markets in which we are active, as well as
our business plans. Words such as "expects", "anticipates",
"intends", "plans", "believes", "seeks", "estimates", "projects",
"forecasts", "may", "should", variations of such words and similar
expressions are intended to identify such forward-looking
statements. The forward-looking statements may include, without
limitation, statements regarding product development, product
potential or financial performance. The forward-looking statements
are subject to risks and uncertainties, which may cause results to
differ materially from those set forth in the statements.
Forward-looking statements in this release should be evaluated
together with the many uncertainties that affect the business of
American CryoStem Corp. and its markets, particularly those
discussed in the risk factors and cautionary statements in filings
made by the Company with the Securities and Exchange Commission.
Forward-looking statements are not guarantees of future
performance, and actual results may differ materially from those
projected. The forward-looking statements are representative only
as of the date they are made, and the Company assumes any
responsibility to update any forward-looking statements, whether as
a result of new information, future events or otherwise.
CONTACT: Investor Relations Contact:
American CryoStem Corporation
John DiFolco
732-747-1007
info@americancryostem.com
www.americancryostem.com
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Aug 2024 to Sep 2024
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Sep 2023 to Sep 2024